From January 1, 2024 to January 28, 2024, the company has repurchased 294,200 shares, representing 0.04% for CNY 1.65 million. With this, the company has completed the repurchase of 8,785,900 shares, representing 1.17% for CNY 50 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.61 CNY | +1.10% |
|
-4.16% | -16.64% |
1st Jan change | Capi. | |
---|---|---|
-16.64% | 447M | |
+25.24% | 45.32B | |
+34.85% | 24.51B | |
+29.56% | 16.85B | |
+21.32% | 14.62B | |
+70.51% | 14.16B | |
-0.05% | 6.79B | |
+15.74% | 5.82B | |
-8.87% | 5.73B | |
+10.29% | 4.93B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.